Scholarly Index
Christopher D. Lao
Bristol-Myers Squibb (United States); 36,906 total citations; 168 total publications; best world rank #64
Bristol-Myers Squibb (United States)
36,906Total citations
168Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 722 | US 359 | 98.45 |
| CAR-T cell therapy research | Lifetime | 845 | US 488 | 97.78 |
| Melanoma and MAPK Pathways | Lifetime | 298 | US 158 | 96.84 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 560 | US 210 | 97.84 |
| CAR-T cell therapy research | 2021-2025 | 363 | US 206 | 97.59 |
| Melanoma and MAPK Pathways | 2021-2025 | 64 | US 19 | 96.56 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 366 | US 91 | 90.49 |